Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Dotmatics introduces new chemistry software for small molecule drug discovery

By Brian Buntz | July 18, 2022

DotmaticsR&D scientific software company Dotmatics has launched Chemistry Solution for Small Molecule Drug Discovery, a software package including applications, workflows and data management capabilities.

Boston-based Dotmatics says the software supports collaboration and productivity between research teams, helps curb operational inefficiencies and supports data-driven decision-making.

The company says the software can help drug developers optimize investments in small molecule science.

In 2021, U.S.-based drug development companies spent $83 billion on drug development, which represents more than tenfold the inflation-adjusted level in the 1980s. Over the past four decades, productivity in research labs has also fallen as workflows have grown more complex and data sets more fragmented.

Dotmatics’ new software offering also provides templates designed to support drug discovery workflows spanning from hit discovery to lead optimization research. Included in the templates are support for design, synthesis, sample logistics, QC analysis, screening and SAR analysis.

Chemistry Solution for Small Molecule Drug Discovery also offers guided visualizations and preconfigured cheminformatics analytics functionalities.

The new software is an outgrowth of Dotmatics’ work on scientific informatics systems for small molecule drug discovery, which began with the company’s inception in 2005. “In that time we have implemented hundreds of systems in organizations around the world,” LeBeau said. “From these we have learned what works, and what doesn’t, to support effective and productive small molecule discovery. The Dotmatics Small Molecule Drug Discovery Solution brings together and codifies all those best practices that we have seen and contributed to over the years.”

Dotmatics started working on the solution in late 2021. “It came together quickly due to the depth of knowledge and skills that has accrued within Dotmatics,” LeBeau added.


Filed Under: Drug Discovery and Development, machine learning and AI
Tagged With: Chemistry Solution for Small Molecule Drug Discovery, Dotmatics
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Portrait photo of Cardinal Health CFO and soon-to-be CEO Jason Hollar
Cardinal Health’s CFO to move up to corner office
CNS
The CNS drug development drum beat is getting louder
DeepMind
7 ways DeepMind’s AlphaFold is being used in life sciences
Biomarker
Bioanalytical method development and validation using Quanterix’s Simoa platform 

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50